These results suggest that Mdmx enhances aerobic glycolysis in conditional transgenic mice, thereby providing further evidence that MDMX may influence the glucose metabolic reprogramming of liver cancer cells via the FOXO1 pathway. This evidence concerns the gene FOXO1 and liver cancer.